Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Up 5.1% in January

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 14,400 shares, a growth of 5.1% from the January 15th total of 13,700 shares. Approximately 2.6% of the shares of the company are sold short. Based on an average daily volume of 401,100 shares, the days-to-cover ratio is currently 0.0 days.

Institutional Investors Weigh In On Bluejay Diagnostics

An institutional investor recently raised its position in Bluejay Diagnostics stock. Anson Funds Management LP raised its stake in Bluejay Diagnostics, Inc. (NASDAQ:BJDX) by 359.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 319,280 shares of the company’s stock after acquiring an additional 249,770 shares during the period. Anson Funds Management LP owned approximately 1.93% of Bluejay Diagnostics worth $41,000 at the end of the most recent quarter. 18.47% of the stock is currently owned by hedge funds and other institutional investors.

Bluejay Diagnostics Trading Down 5.0 %

NASDAQ BJDX traded down $0.19 during trading on Monday, reaching $3.55. The company’s stock had a trading volume of 8,967 shares, compared to its average volume of 51,840. The firm has a 50 day moving average price of $3.89 and a 200 day moving average price of $6.56. Bluejay Diagnostics has a 12 month low of $3.03 and a 12 month high of $386.72. The firm has a market capitalization of $1.95 million, a price-to-earnings ratio of 0.00 and a beta of 0.46.

About Bluejay Diagnostics

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.